DaVita Inc. (DVA) Is Down 9% This Year. Here Is Why

DaVita Inc. (NYSE:DVA) is among the Buffett Stock Portfolio: Top 10 Stock Picks for 2025. The company’s shares have had several fluctuations this year, resulting in a year-to-date decline of over 9%.

Clinical laboratory technicians running tests in the comprehensive kidney care services.

The stock fell sharply in April after a ransomware attack that encrypted certain elements of DaVita Inc. (NYSE:DVA)’s network and impacted some of the company’s operations, according to a regulatory filing.

Investor sentiment has also been dampened by Buffett’s firm, Berkshire Hathaway, reducing its stake in DaVita Inc. (NYSE:DVA) this year. The billionaire investor first offloaded some shares as part of a pre-planned agreement in February, and then in May before a class action lawsuit against the company.

In May, a union health benefits fund sued top dialysis services providers in the U.S. for allegedly artificially inflating treatment costs for billions of dollars. The class action lawsuit accused DaVita Inc. (NYSE:DVA) and Fresenius Medical Care of colluding in parallel price increases that were higher than those of competitors and not explained by market forces.

DaVita Inc. (NYSE:DVA) is one of the largest kidney dialysis providers in the U.S. with 2,661 centers. It also operates 512 dialysis centers in 13 other countries.

While we acknowledge the potential of DVA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Most Undervalued Stocks to Buy for Under $5 and 10 Best Drone Stocks to Buy According to Billionaires.

Disclosure: None.